Cardinal Health, Inc. (NYSE:CAH) Stock Position Lifted by CHURCHILL MANAGEMENT Corp

CHURCHILL MANAGEMENT Corp grew its position in Cardinal Health, Inc. (NYSE:CAH) by 1.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 240,422 shares of the company’s stock after acquiring an additional 3,576 shares during the quarter. Cardinal Health makes up approximately 0.3% of CHURCHILL MANAGEMENT Corp’s holdings, making the stock its 25th largest position. CHURCHILL MANAGEMENT Corp’s holdings in Cardinal Health were worth $28,435,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Point72 Asset Management L.P. bought a new position in shares of Cardinal Health in the 2nd quarter worth about $90,440,000. State Street Corp grew its holdings in shares of Cardinal Health by 4.6% during the third quarter. State Street Corp now owns 14,177,641 shares of the company’s stock valued at $1,566,913,000 after purchasing an additional 627,253 shares during the last quarter. Pacer Advisors Inc. raised its position in shares of Cardinal Health by 9.9% during the 2nd quarter. Pacer Advisors Inc. now owns 4,099,082 shares of the company’s stock worth $403,022,000 after purchasing an additional 370,181 shares during the period. Two Sigma Advisers LP boosted its position in Cardinal Health by 47.9% during the 3rd quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company’s stock valued at $118,197,000 after purchasing an additional 346,362 shares during the period. Finally, Caisse DE Depot ET Placement DU Quebec grew its stake in Cardinal Health by 230.0% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 477,911 shares of the company’s stock worth $52,819,000 after buying an additional 333,095 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Up 0.4 %

NYSE CAH opened at $124.51 on Thursday. The firm’s 50 day moving average is $120.28 and its 200-day moving average is $111.41. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $126.23. The company has a market capitalization of $30.13 billion, a PE ratio of 24.22, a price-to-earnings-growth ratio of 1.47 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last announced its earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The business had revenue of $52.28 billion during the quarter, compared to the consensus estimate of $50.90 billion. During the same quarter in the previous year, the firm posted $1.73 EPS. Cardinal Health’s revenue was down 4.3% compared to the same quarter last year. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 7.82 EPS for the current year.

Cardinal Health Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were given a $0.5056 dividend. The ex-dividend date of this dividend was Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a yield of 1.62%. Cardinal Health’s dividend payout ratio is currently 39.30%.

Analyst Ratings Changes

Several equities analysts have recently commented on CAH shares. Evercore ISI upgraded shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target for the company in a research report on Tuesday, January 7th. Bank of America raised Cardinal Health from a “neutral” rating to a “buy” rating and lifted their price target for the company from $132.00 to $145.00 in a report on Monday, January 6th. Wells Fargo & Company raised Cardinal Health from an “underweight” rating to an “equal weight” rating and increased their price objective for the stock from $101.00 to $127.00 in a report on Friday, December 13th. UBS Group lifted their target price on Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a research note on Monday, November 4th. Finally, Mizuho started coverage on Cardinal Health in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price target for the company. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and an average target price of $133.29.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.